|会议时间||2019-05-10 到 2019-05-11|
4th Healthcare Policy Asia Pacific Summit 2019
May 9-10, 2019 • Singapore
About this Event
Why attend HAP4? (event background)
The market for healthcare in the Asia Pacific region expanded at more than a 12% CAGR from 2012 to 2018, and strong growth is projected for the near future. With continued population growth, increased disposable incomes, and rapid urbanization, the Asia Pacific region is ripe with opportunity for global healthcare providers. However, as government policies and market conditions across the region differ substantially from those of the European and American markets, the continued development of the healthcare industry faces a set of unique challenges.
The 4th Asia Pacific Healthcare Summit 2019 will provide attendees with detailed information on the latest regulatory policies for healthcare across the Asia Pacific region, and offer a platform for healthcare industry professionals to share experiences, and express opinions on optimal business practices in the wake of changes within the industry.
What you will learn (highlights)
-More than 100 Delegates interpreting healthcare regulations in Singapore, Japan, South Korea, Thailand, India, Vietnam, and other major jurisdictions
-Firsthand testimony from government officials and industry leaders on healthcare policy in the APAC region and around the world, as well as future market trends
-Detailed look at the registration process and market access strategy for healthcare products.
-The latest knowledge on quality assurance and regulatory compliance for medical devices and pharmaceuticals
-In-depth analysis of product development and clinical trial requirements in the Asia Pacific region
-Information on cutting-edge innovationintegrating drugs with medical devices
-Challenges and opportunities for medical device supply chains and distributors
-Robust exchange between company representatives and government regulators, in the interest of developing the industry
Speakers to Invite
Health Sciences Authority (HSA), Singapore
The Ministry of Food and Drug Safety (MFDS), Korea
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
The Therapeutic Goods Administration (TGA), Australia
Food and Drug Administration (FDA), Thailand
Ministry of Health Vietnam
Ministry of Health Malaysia
Ministry of Health & Family Welfare (MOHFW), India
World Health Organization (WHO)
The ASEAN Secretariat
Leading International Healthcare Companies
Who should attend?
• Pharmaceutical Companies
• Medical Device Companies
• Medical Merchandising
• Law Firm/Advisor Consulting
• Medical Services
• Insurance Companies
By Job Title
• Top Management
• Government Affairs Director/Manager
• Regulatory Affairs Director/Manager
• Registration Director/Manager
• Quality Assurance/ Compliance
• Medical Affairs Director/Manager
• Business & Marketing Director/Manager
• Public Relations Director/Manager
• External/Corporate Affairs Director/ Manager
• Legal Director/Manager
Some Previous Attendees
3M Asia Pacific Pte Ltd.
Baxter International Inc.-Baxalta
Aspen Pharmacare Holdings Limited
St. Jude Medical
C. R. Bard
Fresenius Medical Care Asia- Pacific Ltd.
GSK (GlaxoSmithKline Pte Ltd)
Takeda Pharmaceutical Company Limited
Janssen Pharmaceuticals, Inc. Johnson & Johnson
Johnson & Johnson
Linde Gas Asia Pte Ltd.
Novartis Asia Pacific Pharmaceuticals Pte Ltd.
Kimberly-Clark Health Care_ Halyard
Air Liquide (China) Holding Co., Ltd.
Cordis (Shanghai) Medical Devices Co., Ltd.
Shire Pharmaceuticals Group plc
Thermo Fisher Scientific Inc
Teva Pharmaceutical Industries Ltd.
Baker & McKenzie
Beckman Coulter Danaher (Danaher Bernstein)
B. Braun Medical Industries SdnBhd
Cook South East Asia
May 9, 2019
Regulatory & Policy Environment in APAC Jurisdictions
May 10, 2019
Market Access and Regulatory Compliance
Clinical Trials and New Product Development
Procurement and Allocation
Quality Assurance and Quality Control
For further information, please contact:
Ms. Cindy CUI
Tel: + 86215258 8005 Ext. 8253